ÌÇÐÄvlog

This cohort study assesses the association of prostate-specific antigen screening with incidence of metastatic prostate cancer in the Veterans Health Administration (VHA) from 2005 to 2019.

This case-control study evaluates meningioma risk following radiotherapy and chemotherapy and identifies possible factors associated with modifying radiation-associated risk in survivors of childhood cancer.

This cohort study examines the association between temporal changes in cancer treatment between 1970 and 1999 and subsequent breast cancer risk among women.

This multicenter, open-label randomized clinical trial conducted in China compares the efficacy and safety of adjuvant capecitabine with concurrent chemoradiotherapy vs concurrent chemoradiotherapy alone for treatment of patients with locoregionally advanced nasopharyngeal carcinoma.

This cohort study uses a novel population-based methodology to estimate the proportion of older adult Medicare Fee-for-Service beneficiaries with cancer who participate in interventional cancer clinical trials.

This cohort study investigates the association among different immunosuppressive regimens for grade 3 and higher immune-related adverse events with overall survival and progression-free survival in a homogeneous cohort of patients with advanced melanoma who were treated with first-line ipilimumab and nivolumab.

This phase 1 dose-escalation trial assesses the safety and tolerability of a combination of olaparib and radiotherapy in patients with triple-negative breast cancer with residual disease after neoadjuvant chemotherapy.

This secondary analysis examines the long-term association of whole-brain radiotherapy and stereotactic radiosurgery with quality of life and cognition outcomes for patients with limited brain metastasis following surgical resection.